BioSpace News Archive

New publication helps raise awareness of the impact of burnout on physicians and patients

The conference will be held October 28-29 at the Wyndham Grand Jupiter at Harbourside Place in Jupiter, Florida.

It was developed by Professor W. Ian Lipkin of Columbia University who is internationally recognized as an authority on the use of molecular methods for pathogen discovery and was the first to use purely molecular methods to identify an infectious agent and a pioneer in the use of high throughput sequencing in pathogen discovery.

Leading Forum for Direct-to-Consumer (DTC) Advertising Thought Leaders Acknowledges Industry Pioneers in Second Annual Honorary Celebration

Commitment builds on enhanced community-based prevention education, prescriber training and utilization management programs

Free event about the impact of high-cost pharmacy claims targets employer education

FDA uses a risk-based approach to monitor these products and to evaluate reports of adverse effects.

Grants from Leading Duchenne Organization Are Result of Community Fundraising Effort to Support Cardiac Priorities in Duchenne

Usona Institute activated its first clinical trial site within NYU School of Medicine, on October 15, 2019 for a Phase 2 clinical trial (PSIL201) investigating the safety and efficacy of psilocybin for major depressive disorder (MDD).

Calviri, Inc., a start-up focused on ending deaths from cancer through unconventional approaches to diagnostics and vaccines, was recently awarded a $300,000 Phase I grant through the Small Business Innovation Research Program (SBIR) at the National Cancer Institute (NCI).